Market Research Logo

BioSeeker Group AB

BioSeeker Group is a business and competitive intelligence company for investment, venture and R&D management of biotechnology and pharmaceutical companies. It serves the needs of individuals, companies, and institutional clients with a diverse range of information and analysis services.

BioSeeker Group has a strong client focus providing decision-makers, investors, and management people with candid, credible research coverage on biotechnology and pharmaceutical companies. The firm is committed to creating value for clients by providing wisdom and high quality services that meet clients' needs. BioSeeker's clients and projects are kept confidential.

...Show More ...Show Less

222 Reports from BioSeeker Group AB

   
  • Epigenetic Therapy in Oncology: Analytical Tool

    ... a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline ... Read More

  • Conjugated Drugs in Oncology: Analytical Tool

    ... a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline ... Read More

  • Cancer Drugs with Biomarker Development: Analytical Tool

    ... from a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage ... Read More

  • Orphan Drugs in Oncology: Analytical Tool

    ... a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline ... Read More

  • Proof-of-Concept (Phase II) Drugs in Oncology: Analytical Tool

    ... professionals from a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late ... Read More

  • Targeting DNA Damage Response (DDR) Pathways in Oncology: Analytical Tool

    ... empower biotech/pharma professionals from a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early ... Read More

  • Biosimilars in Oncology: Analytical Tool

    ... business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis ... Read More

  • Deals & Alliances in Oncology Drug Development: Analytical Tool

    ... biotech/pharma professionals from a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & ... Read More

  • The Latest Sales Figures in Oncology: Analytical Tool

    ... professionals from a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late ... Read More

  • TCR/CAR-T Therapies in Oncology: Analytical Tool

    ... a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline ... Read More

  • Target Atlas in Liver Cancer: A Competitive Outlook

    ... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Liver Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ... Read More

  • Target Atlas in Mesothelioma: A Competitive Outlook

    ... development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Mesothelioma: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, integrated with drug pipeline ... Read More

  • Target Atlas in Sarcomas: A Competitive Outlook

    ... development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Sarcomas: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, integrated with drug pipeline ... Read More

  • Target Atlas in Hematological Cancers: A Competitive Outlook

    ... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Hematological Cancers: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ... Read More

  • Nucleic Acid Therapies in Oncology: Drug Pathway Analyzer

    ... different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 220 drug targets that are included in this drug-pathway analyzing tool. No less than 189 of ... Read More

  • Proteins in Oncology: Drug Pathway Analyzer

    ... The rational for this plethora of treatment strategies is based on our increasing understanding of the 200 drug targets that are included in this drug-pathway analyzing tool. No less than 181 of these have been ... Read More

  • Biologicals in Oncology: Drug Pathway Analyzer

    ... The rational for this plethora of treatment strategies is based on our increasing understanding of the 674 drug targets that are included in this drug-pathway analyzing tool. No less than 607 of these have been ... Read More

  • Conjugated Drugs in Oncology: Drug Pathway Analyzer

    ... types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 211 drug targets that are included in this drug-pathway analyzing tool. No less than 190 of these have ... Read More

  • Target Atlas in Breast Cancer: A Competitive Outlook

    ... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Breast Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ... Read More

  • Target Atlas in Prostate Cancer: A Competitive Outlook

    ... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Prostate Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ... Read More

  • Target Atlas in Colorectal Cancer: A Competitive Outlook

    ... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Colorectal Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ... Read More

  • Lymphoma Drug Pathway Analyzer

    ... treatment strategies is based on our increasing understanding of the 288 drug targets that are included in this drug-pathway analyzing tool. No less than 267 of these have been recorded with mutations and 65 drug ... Read More

  • Colorectal Cancer Drug Pathway Analyzer

    ... plethora of treatment strategies is based on our increasing understanding of the 313 drug targets that are included in this drug-pathway analyzing tool. No less than 301 of these have been recorded with mutations and ... Read More

  • Lung Cancer Drug Pathway Analyzer

    ... plethora of treatment strategies is based on our increasing understanding of the 393 drug targets that are included in this drug-pathway analyzing tool. No less than 369 of these have been recorded with mutations and ... Read More

  • Prostate Cancer Drug Pathway Analyzer

    ... plethora of treatment strategies is based on our increasing understanding of the 317 drug targets that are included in this drug-pathway analyzing tool. No less than 305 of these have been recorded with mutations and ... Read More

1 3 5 6 7 8 9

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook